ArticleIn vivo (Athens, Greece)
Lockdown of Breast Cancer Screening for COVID-19: Possible Scenario.
Article in In vivo (Athens, Greece). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
38 citing papers in PubMed, 1 synthesis or guideline pooled it, 74 citations in OpenAlex.
- Can the Clinical Utility of iBreastExam, a Novel Device, Aid in Optimizing Breast Cancer Diagnosis? A Systematic Review.JCO global oncology · 2023Pooled it
- COVID-19 Pandemic's Effects on Breast Cancer Screening, Staging at Diagnosis at Presentation, Oncologic Management, and Immediate Reconstruction: A Canadian Perspective.Current oncology (Toronto, Ont.) · 2025Article
- Differences in Age, Stage and Biology of Breast Cancer Presentations at A Private Breast Unit in Johannesburg Before and During The COVID-19 Pandemic.European journal of breast health · 2025Article
- The effect of the COVID-19 pandemic on clinical and pathologic stages of patients diagnosed with breast cancer.Irish journal of medical science · 2025Article
- An approach to COVID‑19 and oncology: From impact, staging and management to vaccine outcomes in cancer patients: A systematic review and meta‑analysis.Experimental and therapeutic medicine · 2025Article
- Association of the COVID-19 Pandemic with HbA1c Testing and Complication Screening in Patients with Diabetes Mellitus.Yonsei medical journal · 2024Article
- Impact of Covid-19 on Breast Cancer Screening.Asian Pacific journal of cancer prevention : APJCP · 2024Article
- Neoadjuvant T-DM1 for HER2-positive breast cancer used as a bridging strategy during COVID-19 pandemic: lessons learned-a case series.Gland surgery · 2024Article
- Changes in Screening Test Volume in the National Breast and Cervical Cancer Early Detection Program during the COVID-19 Pandemic, 2020-2022.International journal of environmental research and public health · 2024Article
- Lessons learned from COVID-19: improving breast cancer care post-pandemic from the patient perspective.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2024Article
- PLANNING TO 'NEW NORMAL' DURING COVID-19 PANDEMIC AT GENERAL SURGERY DEPARTMENT: A TURKEY EXPERIENCE.Acta clinica Croatica · 2023Article
- Impact of age, race, and family history on COVID-19-related changes in breast cancer screening among the Boston mammography cohort study.Breast cancer research and treatment · 2023Article
- COVID-19 and Breast Cancer: Analysis of Surgical Management of a Large Referral Center during the 2020-2021 Pandemic Period.Current oncology (Toronto, Ont.) · 2023Article
- Impact of COVID-19 pandemic on breast and cervical cancer screening in Denmark: A register-based study.eLife · 2023Article
- Consequences of the COVID-19 pandemic on the diagnosis and treatment of gastric cancer in referral centers in Italy.Tumori · 2023Article
- Quantification of Extracellular Volume in CT in Neoadjuvant Chemotherapy in Breast Cancer: New Frontiers in Assessing the Cardiotoxicity of Anthracyclines and Trastuzumab.Journal of personalized medicine · 2023Article
- COVID-19 and Breast Cancer in Brazil.International journal of public health · 2023Article
- Long-term effects of the interruption of the Dutch breast cancer screening program due to COVID-19: A modelling study.Preventive medicine · 2023Article
- The Prevalence and Analysis of Related Factors of Anxiety, Depression, and Quality of Life of Out-Patients in the Cancer Institute of a COVID-19 Referral Tertiary Hospital: One Year into the Pandemic.Acta medica Philippina · 2023Article
- Lymphadenopathies before and during the Pandemic COVID-19: Increasing Incidence of Metastases from Solid Tumors.Journal of clinical medicine · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND/
aimCoronavirus disease is spreading worldwide. Due to fast transmission and high fatality rate drastic emergency restrictions were issued. During the lockdown, only urgent medical services are guaranteed. All non-urgent services, as breast cancer (BC) screening, are temporarily suspended. The potential of breast cancer screening programs in increasing the survival rate and decreasing the mortality rate has been widely confirmed. Suspension could lead to worse outcomes for breast cancer patients. Our study aimed to analyse the data and provide estimates regarding the temporary BC screening suspension. PATIENTS AND
methodsData regarding breast cancer and respective screening programs were achieved through literature research and analysis.
resultsConsidering three different scenarios with respect to the lockdown's impact on breast cancer screening, we estimate that approximately 10,000 patients could have a missed diagnosis during these 3 months. Considering a 6-month period, as suggested by the Imperial college model, the number of patients who will not receive a diagnosis will rise to 16,000.
conclusionBreast cancer screening should be resumed as soon as possible in order to avoid further breast cancer missed diagnosis and reduce the impact of delayed diagnosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.